Literature DB >> 3007766

Reduced in vitro 32P incorporation into phospholamban-like protein of sarcolemma due to myocardial ischaemia in anaesthetized pigs.

J M Lamers, J T De Jonge-Stinis, W C Hülsmann, P D Verdouw.   

Abstract

The mechanism of Ca2+ overload production in ischaemia-reperfusion of the heart is unclear. The present study was designed to examine whether loss of second messenger (Ca2+ and cyclic AMP) control of sarcolemmal Ca2+ transport systems occurs during ischaemia. Ischaemic (1, 2 and 3 h duration) and non-ischaemic tissue samples were taken from the coronary-ligated porcine heart and a membrane fraction, enriched in sarcolemmal vesicles, was isolated. The membranes were phosphorylated using [gamma-32P] ATP in the presence of either cyclic AMP or Ca2+-calmodulin. The in vitro 32P incorporation into the electrophoretically separated phospholamban-like protein, became markedly reduced depending on the duration of ischaemia. The reduction could neither be attributed to factors as ischaemia-induced changes in membrane-bound kinase or phosphatase nor in situ phosphorylation of phospholamban. It is postulated that during ischaemia and reperfusion, a deficient control of the sarcolemmal Ca2+ pump by phospholamban-like protein may serve as a source of intracellular Ca2+ overload.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007766     DOI: 10.1016/s0022-2828(86)80464-3

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  2 in total

1.  The effects of dietary mackerel oil on plasma and cell membrane lipids, on hemodynamics and cardiac arrhythmias during recurrent acute ischemia in the pig.

Authors:  J M Hartog; J M Lamers; P D Verdouw
Journal:  Basic Res Cardiol       Date:  1986 Nov-Dec       Impact factor: 17.165

2.  Immunoelectron microscopical localization of phospholamban in adult canine ventricular muscle.

Authors:  A O Jorgensen; L R Jones
Journal:  J Cell Biol       Date:  1987-05       Impact factor: 10.539

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.